Milestone Pharmaceuticals Inc. (MIST)
NASDAQ: MIST · Real-Time Price · USD
0.7572
-0.0070 (-0.92%)
At close: Oct 7, 2026, 4:00 PM EDT
0.763101
+0.0059 (0.78%)
After-hours: Oct 7, 2026, 7:59 PM EDT
Milestone Pharmaceuticals Market Cap
Milestone Pharmaceuticals has a market cap or net worth of $106.7 million as of October 7, 2026. That makes Milestone Pharmaceuticals the world's 25,002nd most valuable company and 4,076th in the United States. Its market cap has decreased by 48.59% in one year.
Market Cap
106.70M
Enterprise Value
77.92M
1-Year Change
-48.59%
Global Rank
Country Rank
#4,076 United States
Category
ChartMarket Cap Chart
Since May 9, 2019, Milestone Pharmaceuticals's market cap has decreased from $363.46M to $106.70M, a decrease of -70.64%. That is a compound annual growth rate of -15.23%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 7, 2026 | 106.70M | -48.00% |
| Dec 31, 2025 | 205.20M | 31.26% |
| Dec 31, 2024 | 156.32M | 117.39% |
| Dec 29, 2023 | 71.91M | -57.49% |
| Dec 30, 2022 | 169.15M | -38.80% |
| Dec 31, 2021 | 276.39M | 38.33% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| May 9, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Coya Therapeutics | 116.21M |
| Corbus Pharmaceuticals Holdings | 113.53M |
| Tevogen | 112.52M |
| Tenax Therapeutics | 112.27M |
| Aardvark Therapeutics | 110.96M |
| Vivani Medical | 110.50M |
| Immunic | 109.70M |
| Rani Therapeutics Holdings | 109.43M |